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ing genes. The quality of the different papers varies, and
although some of them are only descriptions of findings of
different genetic alterations in small series with no emphasis
on the title 'Targets for Therapy', the overall impression of
the book is good. Many of the papers point to the dawning
potential of oncogenes and their products as targets for
specific therapy, and this is exciting reading.
In the first section the epidermal growth-factor receptor
homologue c-erbB-2 is the subject of most papers. The first
paper gives a very good overview of the involvement of this
receptor in human malignant diseases, and its role in the
biology of human cancer. Production of humanised mono-
clonal antibodies directed against the extra cellular domain
of c-erbB-2, their antiproliferative effects on cultured tumour
cell lines and on tumour xenografts seem very promising for
the use of this agent in treatment ofcancers involving overex-
pression of this receptor. Clinical trials have started on both
breast and ovarian cancer patients. Other strategies where
antibodies to c-erbB-2 are coupled to a variety of toxins,
drugs or isotopes are also considered in the following papers.
They also show the importance of the epitope the antibody
recognise in order to be effective in growth inhibition.
Monoclonal antibodies against the EGF receptor also seem
to be clinically useful both for radio-imaging and for
therapeutic applications. These antibodies seem to act as
antagonists of EGF, and such antibodies are now also used
in clinical trials. The last paper in this section deals with the
growing family of fibroblast growth factors (FGFs) and their
receptors as possible targets for therapy. More recent
experiments, unfortunately not included in the book, indicate
that both FGFs and pleiotrophins are likely to be important
in tumour angiogenesis. Antibodies to FGF have been
coupled to toxins and have shown potential anti-cancer
activity toward human breast cancers growing in nude mice.
Section two deals with intracellular oncogene products as
targets for therapy, and particularly the ras oncoproteins.
This section is in my opinion the most exciting and best
written part of the book. The first paper in this section gives
an excellent overview of the mechanisms whereby intracel-
lular antigens reach and can be seen by the host's immune
system, and sets the framework on which therapeutic strat-
egies can be devised. It contains illustrating figures explaining
MHC class I and class II pathways, preparing the reader for
the following papers. The overview of the ras oncogenes and
their clinical potentials in the next chapter gives an excellent
description of the ras signal transduction pathway, and ras
activation in tumorigenesis, diagnosis and prognosis. Poten-
tial strategies for reverting ras transformation are outlined.
This is further explored in chapter 14 where antisense
oligonucleotide and ribozyme technology against ras are des-
cribed; and in chapter 15 where prospects for anti-ras
chemotherapy are covered, showing that the ras-processing
enzymes involved in farnesylation and prenylation are possi-
ble targets for therapy. The frequent occurrence of ras muta-
tions in a range of human malignancies has made the
identification of pharmacological agents that block the func-
tion of the oncogenic ras an important and exciting pos-
sibility in therapy. Mutant ras oncogenes may also be targets
for immunotherapy as discussed in chapter 12 and 13. Other
oncoproteins such as the nuclear proteins myc and jun have
to be much more understood both at the structural and
functional level before they can be used as targets for
therapy, but when this information becomes available they
will surely expand opportunities for pharmaceutical interven-
tion in growth control.
The third section deals with tumour suppressor genes and
immortalising genes. This is the newest scenario of genes
found to be involved in tumorigenesis. However, none of the
papers points to any possibility of using these as targets for
therapy. The function of some of these proteins (both the
normal and mutated counterpart) is today fairly well known,
and should have been included to give the reader a possibility
to associate where in the pathways a possible therapy could
be directed. As a review of tumour suppressor genes and
their involvement in human cancers these papers are too
limited to give the reader an updated knowledge.
Altogether the book is exciting reading and leaves the
reader with an optimism that there are great new potentials
in using gene therapy for treatment of cancer.
A.-L. B0rresen
Handbook of Psychooncology
Edited by J.C. Holland & J.H. Rowland, Oxford: OUP,
1992, 785 pp. £37.50.
Psycho-oncology is a new and rapidly expanding field in both
research and clinical practice. This comprehensive text book
is a welcome contribution, since much of the relevant
literature has been scattered in Oncological and Psycho-
logical Journals over recent years, making it difficult to
assimulate the extensive, available, published material.
The Handbook is wide ranging, drawing on cultural,
psychological and medical aspects of cancer that contribute
to adjustment, as well as special problems posed, for exam-
ple, by cancer in children or in the elderly. It gives detailed
and practical information on important specific areas, includ-
ing principle treatment modalities, cancer sites, significant
adverse effects, psychiatric disorder and sexual dysfunction
and covers a wide range of therapeutic interventions. In
addition, problems for families and staff are reviewed and
chapters on ethics and bereavement find their place. A
notable exclusion is a detailed appraisal of training in com-
munication and counselling skills for health care profes-
sionals working in Oncology, and somewhat brief coverage is
given to important topics such as stress and cancer, and
quality of life research.
The authors unashamedly draw on American research and
clinical practice for this book, but this creates some
imbalance in representing research in the field. Equally, not
all aspects of clinical management in psycho-oncology are
relevant to British Oncology Services, where there are very
few liaison psychiatrists and where the psychotropic drugs
suggested may not be available. Fortunately, other briefer
texts for the British market fill these gaps (such as 'Counsell-
ing and Communication in Health Care' edited by H. Davis
and L. Fallowfield and 'Cancer Patient Care: Psychological
Treatments' edited by M. Watson).
A strength of this Handbook is the integration of research
data to support guidelines in clinical management, although
the layout results in some splitting of information through a
range of different chapters. Good cross-referencing reduces
the frustration of this, but for topics such as depression,
major chapters covering all aspects might have been more
convenient.
This Handbook will undoubtedly become a standard
reference text for this field and the paperback edition
represents good value for the Library of any Hospital where
oncology services are provided. It will appeal to all the
disciplines involved in cancer care because of its wide
coverage, but is a readable text that has something to offer to
the expert as well as the novice.
P. Hopwood
Metastasis: Basic Research and its Clinical Applications
Edited by H. Rabes, P.E. Peters & K. Munk, Basel: Karger,
1992, 394pp. £34.40.
This book reports the proceedings of a Symposium held in
1991 under the auspices of a German Foundation. The
Scheel-Stiftung, according to the preface, is a private Found-
ation which supports cancer research and holds periodic
meetings on different aspects of cancer research. The objec-
tive of the organisers was to bring together theoretical, exper-
imental and clinical research related to metastasis. In its aims
this Symposium resembles many others that have gone before
it. This book suffers, like so many publications of conference448 BOOK REVIEWS
proceedings, in not being up-to-date. There are almost no
references to papers later than 1990, except for some self-
citations which extend to 1991. In addition to well known
major contributors to the field of metastasis, research par-
ticipants were also drawn from laboratories in Continental
Europe, which are not frequently represented at Symposia of
this type.
Some of the papers are general overviews, while others
report the Authors own studies in detail. On the whole the
various contributions are rather disparate, but occasionally
authors compare and contrast a related phenomenon. An
example is the role of the CD-44, a transmembrane protein
involved in lymphocyte transport, for which the group of
Herrlich (Karlsruhe, Germany) have obtained convincing
evidence of a role in metastasis. On the other hand, I.R. Hart
(London, UK) described studies involving a panel of
melanoma cells in which no evidence for a direct involvement
of CD-44 in metastasis was found.
The subject matter is divided into the following sections:
(1) Concepts, Genetic Aspects and Models
(2) Molecular Mechanisms and Modulation of Invasion
and Metastasis
(3) Growth Factors, Angiogenesis, Microvasculature and
Metastasis
(4) Aspects of Metastatic Melanoma
(5) Immunological Aspects and Therapeutic Approaches
(6) New Methods in Radiological Diagnosis, Therapy
Planning and Therapy of Metastasis
The first section has papers dealing with the role of ras
oncogenes and bladder carcinoma and the initial steps in
cancer dissemination of rat bladder carcinoma. These raise
questions without providing any answers.
The second section is concerned principally with cell
adhesion and highlights complexity and conflicting results.
In the third section the discussion of angiogenesis is disap-
pointing and work is reported from investigators who are not
prominent in the area. There is, however, a very valuable
chapter from L. Weiss (Buffalo, New York). He analyses, in
detail, a mechanism for the destruction of cancer cells in the
microvasculature based on deformation. Weiss' data for the
destruction of cancer cells when trapped in capillaries has
long been a key observation in the field of blood-borne
metastatic spread. It leads to the concept of metastatic
inefficiency which is so evident when the relative infrequency
of metastasis is compared with the number of cancer cells
shed into the circulation. Weiss' suggestion as to how this
destruction occurs is compelling and he provides most inter-
esting new data which indicates that treatment of cells with
doxorubicin increases biomechanical destruction. In the sec-
tion on melanoma there are two rather unconvincing con-
tributions on metastasis-associated surface molecules, in
addition to the critical analysis of the role of CD-44 to which
reference has already been made.
The last two sections contain a mixture of topics and on
the whole are of little interest. Immunotherapy with
autologous tumour 'vaccines' are reported by investigators
from Pittsburgh and Heidelberg with claims of benefits being
made on the basis of episodic observations. There is a sense
of deja vu as the investigators do not appear to have taken
account of past studies in which claims based on isolated
cases failed to be substantiated in properly controlled trials.
The last section contains reports on the use of radio-
labelled monoclonal antibodies for diagnosis and therapy.
The conclusions do not differ from those which have
previously been reported, namely, that expectations greatly
exceed actual performance. However, the paper from Weiss-
leder (Harvard Medical School, USA) appears to open a new
field; the use of contrast agents for magnetic resonance imag-
ing of liver metastasis by receptor targeting of iron in the
liver via the asialoglycoprotein receptor.
The usefulness and value of this volume is limited, but it
probably deserves a place in the libraries of larger Cancer
Research Institutes.
P. Alexander
Atlas of Tumor Pathology - Tumors of the Cervix, Vagina,
and Vulva
R.J. Kurman, H.J. Norris & E. Wilkinson, Washington DC:
Armed Forces Institute of Pathology, 1992, 262pp.
Over the years since its inception in 1947, the Atlas ofTumor
Pathology (known colloquially as 'the Fascicles') has estab-
lished a well-deserved reputation for authoritative and prac-
tical coverage of the surgical pathology of tumours, and has
been influential in promoting the standardisation of tumour
nomenclature. The latest addition to the Third Series, on
tumours of cervix, vagina and vulva, will undoubtedly find
its way onto the bookshelves of countless diagnostic patho-
logists worldwide, and rightly so. As well as being a com-
prehensive guide to the histological diagnosis of neoplasms
and tumour-like lesions, the Fascicles have developed into
monographs promoting consistent terminology, and provid-
ing relevant information on histogenesis, pathogenesis and
clinico-pathological features of lesions. The Fascicles are
published at virtually cost price, and this ensures widespread
accessibility. There is a great deal of information distilled
into a relatively slim volume of 262 pages, and although
continuing to serve as a practical bench guide for the busy
diagnostic pathologist, the text of this Fascicle is well written
and easy to read at more leisure. As we have come to expect,
the illustrations (almost all black and white) are of excellent
quality throughout, and the references are well chosen and
up-to-date.
The first chapters cover embryology and anatomy of the
lower female genital tract, followed by a review of Human
Papillomaviruses, the latter incorporating a brief but useful
section on their molecular biology and association with neo-
plasia. The rest of the book is devoted to a systematic and
very comprehensive coverage of the great variety of tumours
and tumour-like conditions to which these sites are suscep-
tible. The section on cervical intraepithelial neoplasia (CIN)
is well illustrated, and the text is clear and succinct, but not
all pathologists will be comfortable with the classification of
CIN (influenced by the Bethesda System) into low grade and
high grade lesions. The low grade category combines CINI
with atypia of condylomatous and koilocytotic types, and is
often associated with infection by the 'low-risk' HPV types,
but it carries the potentially risky implication that the lesion
is unlikely to progress and does not require treatment.
The chapters devoted to a systematic consideration of
individual tumours of cervix, vagina and vulva are admirable,
and give an excellent blend ofpractical diagnostic description
and clinico-pathological information. I can whole-heartedly
recommend this Fascicle to all surgical pathologists - it
contains well illustrated descriptions of all the tumours which
most of us are ever likely to encounter - plus a few more! It
will also be useful to others in the field ofoncology who need
accurate and up-to-date information on histological and
clinico-pathological features of tumours of the lower female
genital tract.
A.R.W. Williams
Protein Kinase C
Edited by D.S. Lester & R.M. Epand, Chichester: Ellis Hor-
wood, 1992, 365 pp. £59.00.
The discovery of the enzyme protein kinase C (PKC) in the
late seventies and the finding that it is the receptor for
phorbol ester tumour promoters and at the heart ofprocesses
mediating cellular proliferation and differentiation has led to
the publication of several thousand papers on this enzyme
during the last decade. In the case of a research areas as
expansive and at times confusing as that associated with
PKC it is beneficial to find editors and authors who are
prepared to review the field with the intent to integrate
existing evidence and to render it more easily digestible.
David D. Lester and Richard M. Epand have undertaken the
formidable task to do just that by editing a book which aims